Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting STAT3 and STAT5 in Tumor-Associated Immune Cells to Improve Immunotherapy
Grégory Verdeil, Toby Lawrence, Anne‐Marie Schmitt‐Verhulst, et al.
Cancers (2019) Vol. 11, Iss. 12, pp. 1832-1832
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

STAT3, a Master Regulator of Anti-Tumor Immune Response
Cédric Rébé, François Ghiringhelli
Cancers (2019) Vol. 11, Iss. 9, pp. 1280-1280
Open Access | Times Cited: 98
Expression of Immune Related Genes and Possible Regulatory Mechanisms in Alzheimer’s Disease
Yanjun Lu, Ke Li, Yu Hu, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 59
Hypoxia-induced ZEB1 promotes cervical cancer immune evasion by strengthening the CD47-SIRPα axis
Xiaojing Chen, Chu-Hong Guo, Zi‐Ci Wang, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 12
Targeting of TAMs: can we be more clever than cancer cells?
Julia Kzhyshkowska, Jiaxin Shen, Irina Larionova
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 12, pp. 1376-1409
Open Access | Times Cited: 11
Chronic Stress Mediates Inflammatory Cytokines Alterations and Its Role in Tumorigenesis
Zhihan Liu, Lei Meng, Yanxia Bai
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 1067-1090
Open Access | Times Cited: 1
Involvement of STAT5 in Oncogenesis
Clarissa Esmeralda Halim, Shuo Deng, Mei Shan Ong, et al.
Biomedicines (2020) Vol. 8, Iss. 9, pp. 316-316
Open Access | Times Cited: 64
Functionalized Nanoparticles Targeting Tumor-Associated Macrophages as Cancer Therapy
Yuanyuan He, Raimundo Fernandes de Araújo Júnior, Luis J. Cruz, et al.
Pharmaceutics (2021) Vol. 13, Iss. 10, pp. 1670-1670
Open Access | Times Cited: 50
Cucurbitacin B controls M2 macrophage polarization to suppresses metastasis via targeting JAK-2/STAT3 signalling pathway in colorectal cancer
Haoyue Zhang, Bei Zhao, Huizhen Wei, et al.
Journal of Ethnopharmacology (2021) Vol. 287, pp. 114915-114915
Closed Access | Times Cited: 45
In vitro study of cold atmospheric plasma-activated liquids inhibits malignant melanoma by affecting macrophage polarization through the ROS/JAK2/STAT1 pathway
Cheng Chen, Shiyun Zhou, Xingyu Yang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116657-116657
Open Access | Times Cited: 5
Effector CD8 T cell differentiation in primary and breakthrough SARS-CoV-2 infection in mice
Brock Kingstad-Bakke, Woojong Lee, Boyd L. Yount, et al.
Communications Biology (2025) Vol. 8, Iss. 1
Open Access
STAT3: A key signaling molecule for converting cold to hot tumors
Rui Hu, Qiuju Han, Jian Zhang
Cancer Letters (2020) Vol. 489, pp. 29-40
Open Access | Times Cited: 34
Distinct Immune Signatures Indicative of Treatment Response and Immune-Related Adverse Events in Melanoma Patients under Immune Checkpoint Inhibitor Therapy
Robin Reschke, Philipp Gussek, Andreas Boldt, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 8017-8017
Open Access | Times Cited: 26
Identification of Iron Metabolism-Related Genes as Prognostic Indicators for Lower-Grade Glioma
Shenbin Xu, Zefeng Wang, Juan Ye, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 26
SCG2 is a Prognostic Biomarker Associated With Immune Infiltration and Macrophage Polarization in Colorectal Cancer
Hao Wang, Jinwen Yin, Yuntian Hong, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 9
Open Access | Times Cited: 17
The mechanisms on evasion of anti-tumor immune responses in gastric cancer
Junyang Wang, Tong Liu, Tao Huang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 16
Intrinsic RIG-I restrains STAT5 activation to modulate anti-tumor activity of CD8+ T cells
Xinyi Jiang, Jian Lin, Chengfang Shangguan, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 9
Open Access | Times Cited: 10
Dual-Targeted Self-Adjuvant Heterocyclic Lipidoid@Polyester Hybrid Nanovaccines for Boosting Cancer Immunotherapy
Zixu Liu, Boyuan Liu, Yupeng Feng, et al.
ACS Nano (2024) Vol. 18, Iss. 24, pp. 15557-15575
Closed Access | Times Cited: 3
Role of cellular, molecular and tumor microenvironment in hepatocellular carcinoma: Possible targets and future directions in the regorafenib era
Sarun Juengpanich, Win Topatana, Chen Lü, et al.
International Journal of Cancer (2020) Vol. 147, Iss. 7, pp. 1778-1792
Open Access | Times Cited: 27
The self-adjuvant heterocyclic lipid nanoparticles encapsulated with vaccine and STAT3 siRNA boost cancer immunotherapy through DLN-targeted and STING pathway
Zixu Liu, Qingqing Wang, Yupeng Feng, et al.
Chemical Engineering Journal (2023) Vol. 475, pp. 146474-146474
Closed Access | Times Cited: 8
Self-assembling, pH-responsive nanoflowers for inhibiting PAD4 and neutrophil extracellular trap formation and improving the tumor immune microenvironment
Di Zhu, Yu Lu, Lin Gui, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 5, pp. 2592-2608
Open Access | Times Cited: 20
EGCG Targeting STAT3 transcriptionally represses PLXNC1 to inhibit M2 polarization Mediated by Gastric Cancer cell-derived Exosomal miR-92b-5p
Jianfeng Yi, Zhenzhen Ye, Hao Xu, et al.
Phytomedicine (2024) Vol. 135, pp. 156137-156137
Closed Access | Times Cited: 2
Identification of a Prognostic Model Based on Immune-Related Genes of Lung Squamous Cell Carcinoma
Rui Li, Xiao Liu, Xijia Zhou, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 20
Identification of Potential Biomarkers for Anti-PD-1 Therapy in Melanoma by Weighted Correlation Network Analysis
Xuanyi Wang, Zixuan Chai, Yinghong Li, et al.
Genes (2020) Vol. 11, Iss. 4, pp. 435-435
Open Access | Times Cited: 19
Liraglutide activates nature killer cell-mediated antitumor responses by inhibiting IL-6/STAT3 signaling in hepatocellular carcinoma
Xian Lu, C. F. Xu, Jie Dong, et al.
Translational Oncology (2020) Vol. 14, Iss. 1, pp. 100872-100872
Open Access | Times Cited: 19
Fasudil prevents liver fibrosis via activating natural killer cells and suppressing hepatic stellate cells
Qiuju Han, Yongliang Mu, Huajun Zhao, et al.
World Journal of Gastroenterology (2021) Vol. 27, Iss. 24, pp. 3581-3594
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top